What Do We Do With the Science of Monstrous Men?
By Daniel Engber,
Slate
| 07. 31. 2018
On May 18, W. French Anderson, known as the “father of gene therapy,” was released from prison on parole. Two weeks later, the 81-year-old scientist, pediatrician, and ex-con welcomed science writer Sharon Begley to his home in California for several days of interviews, which he gave with a GPS tracking device encircling his ankle. “This is what it has come to for a world-renowned scientist who was convicted of sexually molesting a colleague’s young daughter,” she writes at the top of her warm, weird, and at times outrageous profile for STAT last week.
There’s been a lot of talk, in recent months, about the legacies of monstrous men in the arts. We’ve reviewed the benefits and risks associated with their public shaming. We’ve re-appraised their prior work. We’ve wondered whether prodigious talents should be allowed to re-emerge and keep creating; and then we’ve theorized that our love of second chances enabled them from the start. Much less consideration has been given to the Monstrous Men in Science—the sundry research “pioneers” and “geniuses” who have turned out to be abusive bullies...
Related Articles
By Harry Hunter, PET BioNews | 08.11.2025
The Parliamentary Office of Science and Technology has announced plans to publish a POSTnote and called for submissions on surrogacy law in the UK and internationally.
The current UK surrogacy laws, largely based on legislation from the 1980s, have been...
By Sayantani DasGupta, MedPage Today | 08.05.2025
It's just a jeans ad.
It's not that deep.
It's just social media outrage.
Should physicians care about the recent American Eagle "Sydney Sweeney Has Good Genes Jeans" controversy? What, if anything, does the provocative campaign have to...
By Zusha Elinson, The Wall Street Journal | 08.12.2025
BERKELEY, Calif.—Tsvi Benson-Tilsen, a mathematician, spent seven years researching how to keep an advanced form of artificial intelligence from destroying humanity before he concluded that stopping it wasn’t possible—at least anytime soon.
Now, he’s turned his considerable brainpower to promoting...
By Gregory Laub and Hannah Glaser, MedPage Today | 08.07.2025
In this MedPage Today interview, Leigh Turner, PhD, a professor of health policy and bioethics at the University of California Irvine, unpacks the growing influence of stem cell clinics and the blurred line between medicine and marketing. He explains how...